Search

everythinglearnresearchcommunity

for

Search:↓

Possible link between androgens and COVID-19 severity; more research needed.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Polycystic ovary syndrome (PCOS) is a major health issue for women in Egypt, affecting 14% of fertile women and 37.5% of infertile women.

Young women with PCOS and no other heart risk factors have normal heart function.

Researchers had trouble finding enough participants for a trial on DHEA's effects on postmenopausal women's sexual desire.

Early treatment of PCOS is crucial for better health and quality of life.

Different levels of anti-Müllerian hormone can help diagnose polycystic ovary syndrome in women of different ages.

People with polycystic ovary syndrome (PCOS) are more likely to have higher levels of depression and anxiety, but their personality traits are similar to those without PCOS.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Simvastatin may help manage symptoms in women with non-classic congenital adrenal hyperplasia by lowering cholesterol and certain hormone levels.

Biomaterial characteristics can influence macrophages to promote healing and improve tissue regeneration.

PRP shows promise for spinal pain but needs more guidelines before widespread use.

Newly found stem cells in horse hooves show promise for treating a hoof disease called laminitis.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Hair loss led to the diagnosis of Cushing's disease in a patient, showing that hair loss can be a sign of hormonal disorders.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Nanoparticles improve cancer treatment by reducing side effects and targeting cancer cells better.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Long-term steroid abuse in athletes causes serious health risks, outweighing any benefits.

Ciproterone acetate improves hair regrowth and acne in most female patients.

Nano-quercetin improves quercetin's effectiveness in treating diseases but faces challenges in safety and production.

Provide individualized, supportive care for transgender and non-binary adolescents to improve their well-being.

Doctors should watch for and treat hormonal issues in obese patients beyond just diabetes.

Medications for PCOS don't seem to raise heart disease risk.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

The document explains the difficulty in diagnosing and treating brain diseases caused by the immune system and stresses the need for quick and accurate tests.

Anti-androgens are safe and effective for treating moderate to severe adult female acne.

Understanding gender differences and individual patient characteristics is essential for optimal cosmetic surgery outcomes.